Pharmacoeconomic Aspects of the Prevention of Venous Thromboembolic Events After Large Joints Replacement

Rational Pharmacotherapy in Cardiology - Russian Federation
doi 10.20996/1819-6446-2015-11-3-287-292
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Related search

Meta Regression Analysis to Indirectly Compare Dalteparin to Enoxaparin for the Prevention of Venous Thromboembolic Events Following Total Hip Replacement

Thrombosis Journal
Hematology
2011English

Prevention and Treatment of Venous Thromboembolic Disease

Prescriber
Pharmacology
2018English

Extended Anticoagulation for the Secondary Prevention of Venous Thromboembolic Events: An Updated Network Meta-Analysis

PLoS ONE
Multidisciplinary
2019English

Venous Thromboembolic Events During Warm Autoimmune Hemolytic Anemia

PLoS ONE
Multidisciplinary
2018English

Factor v Leiden, Hormone Replacement Therapy, and Risk of Venous Thromboembolic Events in Women With Coronary Disease

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2002English

The Risk of Arterial Thromboembolic Events After Cancer Diagnosis

Research and Practice in Thrombosis and Haemostasis
2019English

Venous Thromboembolic Events in Critically Ill Traumatic Brain Injury Patients

Intensive Care Medicine
Critical CareIntensive Care Medicine
2016English

Prevention of Thromboembolic Complications of Atrial Fibrillation: Current Aspects and Perspective

Srce i krvni sudovi
2012English

Response To: ‘Venous Thromboembolic Events in Systemic Vasculitis’ by Novikovet Al

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy